Figure 1.
Expression of FKBP5 was increased in advanced thyroid cancer and was associated with a poor prognosis. (a) Immunohistochemistry (IHC) detection of FKBP5 expression in thyroid cancer specimens. High and low expression were defined according to the median cut-off value. Representative images shown at ×100 and ×200 magnification. (b) IHC detection of FKBP5 expression in normal thyroid tissues. Representative images shown at ×100 and ×200 magnification. (c) Kaplan–Meier curves for overall and progression-free survival rates in patients with thyroid cancer in relation to FKBP5 expression level, with median expression level as the cut-off. *P < 0.05.